Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Bibliographic Details
Main Authors:	V. La, R. Fujikawa, D. M. Janzen, M. Nunez, L. Bainvoll, L. Hwang, K. Faull, G. Lawson, S. Memarzadeh
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-08-01
Series:	npj Precision Oncology
Online Access:	https://doi.org/10.1038/s41698-021-00217-9

Similar Items

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
by: V. La, et al.
Published: (2017-04-01)

Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation
by: Jieqiong Zhang, et al.
Published: (2019-05-01)

Cytoplasmic and Nuclear Functions of cIAP1
by: Aymeric Zadoroznyj, et al.
Published: (2022-02-01)

Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation
by: Dowling Catherine, et al.
Published: (2009-06-01)

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.
by: Virginia Morón-Calvente, et al.
Published: (2018-01-01)

E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding.
by: Jennifer Allègre, et al.
Published: (2018-01-01)

IKK∊-Mediated Tumorigenesis Requires K63-Linked Polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 Ubiquitin Ligase Complex
by: Alicia Y. Zhou, et al.
Published: (2013-03-01)

The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity
by: Edward Z. Song, et al.
Published: (2022-12-01)

cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection.
by: Hridayesh Prakash, et al.
Published: (2009-08-01)

TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
by: Xu Yang, et al.
Published: (2022-12-01)

Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis
by: Debolina D. Biswas, et al.
Published: (2022-06-01)

TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating cIAP1 Signals
by: Lili Liang, et al.
Published: (2020-04-01)

Loss of cIAP1 in Endothelial Cells Limits Metastatic Extravasation through Tumor-Derived Lymphotoxin Alpha
by: Lazaros Vasilikos, et al.
Published: (2021-02-01)

Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
by: D. M. Janzen, et al.
Published: (2020-04-01)

A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes
by: Maria Feoktistova, et al.
Published: (2020-02-01)

Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies
by: Lam Stephen, et al.
Published: (2005-12-01)

Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy
by: Neena Lala-Tabbert, et al.
Published: (2019-05-01)

E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer
by: Nicholson, J, et al.
Published: (2017)

cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs
by: Kawalkowska, JZ, et al.
Published: (2019)

Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating cIAP2/NFκB signaling
by: Ru Wang, et al.
Published: (2023-06-01)

Role of the TWEAK-Fn14-cIAP1-NF-kB signaling axis in the regulation of myogenesis and muscle homeostasis
by: Emeka K Enwere, et al.
Published: (2014-02-01)

Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells
by: Anqi Wang, et al.
Published: (2021-02-01)

TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs
by: Monika Vashisht, et al.
Published: (2023-09-01)

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation
by: Weiyan Zhang, et al.
Published: (2024-03-01)

Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018-02-01)

The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
by: Julia Fleischmann, et al.
Published: (2023-06-01)

Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms
by: Gronemeyer Hinrich, et al.
Published: (2010-01-01)

Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells
by: Jin Niu, et al.
Published: (2020-10-01)

cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).
by: Mathieu J M Bertrand, et al.
Published: (2011-01-01)

Combinatorial Treatment of Birinapant and Zosuquidar Enhances Effective Control of HBV Replication In Vivo
by: Emma Morrish, et al.
Published: (2020-08-01)

A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
by: Xiang Ling, et al.
Published: (2012-01-01)

An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
by: Yung-Chieh Chang, et al.
Published: (2020-12-01)

Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations
by: Marika Colombo, et al.
Published: (2020-10-01)

Dual Targeting of the p38 MAPK-HO-1 Axis and cIAP1/XIAP by Demethoxycurcumin Triggers Caspase-Mediated Apoptotic Cell Death in Oral Squamous Cell Carcinoma Cells
by: Ming-Hsien Chien, et al.
Published: (2020-03-01)

ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer
by: Wenda Ye, et al.
Published: (2020-01-01)

PDP-6 IAP
by: White, John L.
Published: (2004)

XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1β Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation
by: Kate E. Lawlor, et al.
Published: (2017-07-01)

Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity.
by: Maria Eugenia Guicciardi, et al.
Published: (2014-01-01)

Multi‐Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018-09-01)

Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
by: Hanieh Meteran, et al.
Published: (2024-02-01)